Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has provided an announcement.
MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license at one of its stores in Karnataka. This suspension, issued by the Drugs Control Administration in Bangalore, will last for three days and is expected to result in a potential revenue loss of approximately Rs 0.37 lacs. The suspension is due to violations under the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945. This development could impact the company’s operations and market positioning, highlighting the importance of regulatory compliance for stakeholders.
More about MedPlus Health Services Ltd.
MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical products and health services. The company is based in Hyderabad, India, and is known for its extensive network of retail pharmacies across the country.
Average Trading Volume: 7,083
Current Market Cap: 102.9B INR
Learn more about MEDPLUS stock on TipRanks’ Stock Analysis page.